[1] Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma[J]. Hepatology, 2011,54(1):173-184.
[2] Blechacz B.
Cholangiocarcinoma: current knowledge and
new developments[J]. Gut Liver, 2017,11(1):13-26.
[3] Khan SA, Tavolari S, Brandi G.
Cholangiocarcinoma: Epidemiology and risk
factors[J]. Liver Int, 2019,39(Suppl 1):19-31.
[4] Andersen JB. Molecular
pathogenesis of intrahepatic cholangiocarcinoma[J]. J Hepatobiliary Pancreat Sci, 2015,22(2):101-113.
[5] 邝曾书瑜,
饶乐,
罗碧源,
等. 512例胆管细胞癌的临床及预后特点[J].中南大学学报(医学版),2020,45(11):1283-1290.
[6] Long J, Huang S, Bai Y, et al. Transcriptional landscape of cholangiocarcinoma revealed by
weighted gene coexpression network analysis[J]. Brief Bioinform, 2021,22(4):bbaa224.
[7] Du J, Lan T, Liao H, et al. CircNFIB
inhibits tumor growth and metastasis through suppressing MEK1/ERK signaling in
intrahepatic cholangiocarcinoma[J]. Mol Cancer, 2022,21(1):18.
[8] Liu H, Zhou Q, Xu X, et al. ASPM and TROAP gene expression as potential malignant tumor
markers[J]. Ann Transl Med, 2022,10(10):586-599.
[9] Zhao ZQ, Wu XJ, Cheng YH, et al. TROAP regulates
cell cycle and promotes tumor progression through Wnt/β-Catenin signaling pathway in glioma cells[J]. CNS Neurosci Ther, 2021,27(9):1064-1076.
[10] Jing K, Mao Q, Ma P. Decreased expression of TROAP
suppresses cellular proliferation, migration and invasion
in gastric cancer[J]. Mol Med Rep, 2018,18(3):3020-3026.
[11] Ye J, Chu C, Chen M, et al. TROAP regulates
prostate cancer progression via the WNT3/survivin signalling pathways[J]. Oncol Rep, 2019,41(2):1169-1179.
[12] Yang S, Liu X, Yin Y, et al. Tastin is
required for bipolar spindle assembly and centrosome integrity during mitosis[J]. FASEB J, 2008, 22(6):1960-1972.
[13] Li K, Zhang R, Wei M, et al. TROAP promotes breast cancer proliferation and metastasis[J]. Biomed Res Int, 2019, 2019:6140951-6140958.
[14] Hu H, Xu L, Chen Y, et al. The upregulation
of trophinin-associated protein (TROAP) predicts a poor prognosis in hepatocellular carcinoma[J]. J Cancer, 2019,10(4):957-967.
[15] 雷宇, 黄山, 路燕. 肺腺癌组织中Trophinin 相关蛋白的表达及临床病理联系[J].安徽医科大学学报, 2020,55(1):118-123.
[16] 于澜, 徐缨龙,
李明,
等. 肝细胞癌组织TROAP表达与上皮-间质转化的相关性[J].胃肠病学和肝病学杂志,2022,31(10):1183-1188.
[17] 孙阁阁.
TROAP对人正常肝细胞HL-7702与肝癌细胞HepG2的增殖调控机理研究 [D].河南师范大学,2021.
[18] Lian Y, Fan W, Huang Y, et al. Downregulated
trophinin-associated protein plays a critical role in human hepatocellular
carcinoma through upregulation of tumor cell growth and migration[J]. Oncol Res, 2018,26(5):691-701.
[19] Janiszewska M, Primi MC, Izard T. Cell adhesion
in cancer: Beyond the migration of single cells[J]. J Biol Chem, 2020,295(8):2495-2505.
[20] Mège RM, Ishiyama N. Integration of cadherin adhesion and cytoskeleton at
adherens junctions[J]. Cold Spring Harb Perspect Biol, 2017,9(5):028738-028755.
[21] 刘婷, 张林西. 上皮间质转化在消化系统肿瘤中的研究进展[J].河北北方学院学报(自然科学版), 2023,39(2):52-56.
[22] Luo Y, Yu T, Zhang Q, et al. Upregulated N-cadherin expression is associated with poor prognosis in epithelial-derived solid tumours: A meta-analysis[J]. Eur J Clin Invest, 2018,48(4):12903-12916.
[23] 闫丽锟. 胚胎停止发育的分子免疫机制研究[D].青岛大学,2016.
[24] Michiko NF, Kazuhiro S. 人类胚胎植入过程中的细胞黏附分子(英文) [J].生理学报,2012,64(3):247-258.
[25] 王磊. 乳腺癌肺转移相关基因的研究[D].复旦大学,2006.
[26] 董家刚.
Trophinin基因在胰腺癌组织中的表达及其临床意义[D].重庆医科大学,2011.
[27] Kaszak I, Witkowska-Piłaszewicz O, Niewiadomska Z, et al. Role of cadherins in cancer: A
review[J]. Int J Mol Sci, 2020,21(20):7624-7640.
[28] Han SP, Yap AS. The cytoskeleton and classical cadherin adhesions[J]. Subcell Biochem, 2012,60:111-135.
|